Zobrazeno 1 - 8
of 8
pro vyhledávání: '"K. Yu. Slashchuk"'
Autor:
K. Yu. Slashchuk, M. V. Degtyarev, P. O. Rumyantsev, A. K. Eremkina, N. V. Tarbaeva, D. G. Beltsevich, I. V. Kim, G. A. Melnicthhenko, N. G. Mokrysheva
Publikováno v:
Опухоли головы и шеи, Vol 11, Iss 4, Pp 10-21 (2022)
Introduction. Primary hyperparathyroidism is one of the most common diseases of the endocrine system, after diabetes mellitus and thyroid pathologies. Early diagnosis and treatment of primary hyperparathyroidism allow avoiding severe damage to the bo
Externí odkaz:
https://doaj.org/article/268f75a322dc437ea4307a34556a367c
Autor:
P. A. Nikiforovich, P. O. Rumiantsev, I. V. Sleptsov, T. V. Ustinova, K. Yu. Slashchuk, S. L. Vorobyev, S. S. Serzhenko, A. Yu. Abrosimov, A. V. Kudryavtseva, A. A. Semenov, R. A. Chernikov, A. A. Polyakov, A. A. Fedenko, L. V. Bolotina, A. A. Paychadze, A. Y. Trushin, A. D. Kaprin, G. S. Zakharova
Publikováno v:
Сибирский онкологический журнал, Vol 19, Iss 5, Pp 131-144 (2020)
Anaplastic thyroid cancer is one of the most aggressive and fatal human carcinomas. A significant experience in using various kinase inhibitors for anaplastic thyroid cancer therapy has been accumulated worldwide. The most encouraging results were ob
Externí odkaz:
https://doaj.org/article/ec6e4b85a5e14e43b17b32835f976c57
Autor:
E. V. Borodavina, P. A. Isaev, A. Yu. Shurinov, P. O. Rumyantsev, V. V. Krylov, K. M. Petrosyan, A. D. Kaprin, S. A. Ivanov, S. O. Podvyaznikov, I. S. Romanov, A. M. Mudunov, K. Yu. Slashchuk, R. S. Zhikhorev, M. V. Volkonsky, R. M. Chagova, I. R. Suslova, A. I. Khryapa, A. Kh. Lepshokova, N. L. Fadeeva, A. R. Safarova, L. P. Kaleykina, E. V. Lymar, E. M. Chernyakova, O. A. Snezhko, A. E. Zinkovskaya, F. F. Mufazalov, E. S. Kuzmina, Yu. V. Druzhinina, Sh. I. Musin, M. R. Mukhitova, A. I. Khasanova, S. Z. Safina, S. L. Kirienko
Publikováno v:
Опухоли головы и шеи, Vol 10, Iss 1, Pp 65-72 (2020)
Background. The implementation of tyrosine kinase inhibitors into clinical practice improved treatment outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). Lenvatinib is recommended as a first-line drug for these p
Externí odkaz:
https://doaj.org/article/90b3f88358a64191b3df59c14333279c
Autor:
I. I. Dedov, G. A. Melnichenko, N. G. Mokrysheva, E. N. Andreeva, M. B. Antsiferov, D. G. Beltsevich, E. E. Bibik, A. M. Gorbacheva, M. V. Degtyarev, L. V. Yeghshatyan, A. K. Eremkina, T. L. Karonova, I. V. Kim, J. A. Krupinova, I. V. Kryukova, N. S. Kuznetsov, S. V. Lukyanov, E. O. Mamedova, N. V. Markina, S. S. Mirnaya, E. A. Pigarova, L. Ya. Rozhinskaya, K. Yu. Slashchuk, I. V. Sleptsov, N. B. Chagai
Publikováno v:
Endocrine Surgery. 16:5-54
The article presents a draft of clinical recommendations for the diagnosis and treatment of primary hyperparathyroidism in adult patients, which provides a modern examination algorithm, discusses the basic principles of laboratory, instrumental diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1024e1f3d249eadb44f2084ef85d2b5a
https://doi.org/10.14341/serg12790
https://doi.org/10.14341/serg12790
Publikováno v:
Endocrine Surgery. 15:41-47
Nowadays, diabetes and diseases of thyroid gland take place on the first two stage in the rank of all endocrine diseases. There are 3 directions to treat thyroid glands pathologies such as: using special pills which substitute natural thyroid hormone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95a257bed2d5f64ff70e6b452ef9d84d
https://doi.org/10.14341/serg12724
https://doi.org/10.14341/serg12724
Autor:
A. I. Khryapa, E. M. Chernyakova, F. F. Mufazalov, E. V. Lymar, S. A. Ivanov, K. Yu. Slashchuk, N. L. Fadeeva, R. M. Chagova, V. V. Krylov, A. R. Safarova, A. M. Mudunov, S. Z. Safina, M. R. Mukhitova, A. I. Khasanova, S. O. Podvyaznikov, K. M. Petrosyan, I. R. Suslova, R. S. Zhikhorev, A. Kh. Lepshokova, P. A. Isaev, S. L. Kirienko, Yu. V. Druzhinina, I. S. Romanov, E. S. Kuzmina, Andrey Kaprin, Sh. I. Musin, O. A. Snezhko, A. Yu. Shurinov, L. P. Kaleykina, A. E. Zinkovskaya, Pavel O. Rumyantsev, M. V. Volkonsky, E. V. Borodavina
Publikováno v:
Opuholi Golovy i Šei, Vol 10, Iss 1, Pp 65-72 (2020)
Background. The implementation of tyrosine kinase inhibitors into clinical practice improved treatment outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). Lenvatinib is recommended as a first-line drug for these p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a048aaf0f080825f30978d7d8770c6d6
https://ogsh.abvpress.ru/jour/article/view/478
https://ogsh.abvpress.ru/jour/article/view/478
Publikováno v:
Khirurgiia. (9)
Ectopic ACTH-syndrome is a relatively rare neuroendocrine disease. It is characterized by hypercortisolemia-associated severe complications that justifies need for timely diagnosis and radical therapy. Case report of young patient with ACTH-producing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c98a5c060a702d31dfbd54d00f5ad7b6
https://pubmed.ncbi.nlm.nih.gov/30307421
https://pubmed.ncbi.nlm.nih.gov/30307421
Autor:
Ya I Sirota, Yu V Shtotsky, V. G. Nikitaev, Pavel O. Rumyantsev, A. N. Pronichev, K S Nizhegorodova, L. Yu. Dubov, Marina S. Sheremeta, K Yu Slashchuk, Mikhail V. Degtyarev, Alexey A. Trukhin
Publikováno v:
KnE Energy. 3:428
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be0a3a19a06064b03611baf96e9f4e0d
https://doi.org/10.18502/ken.v3i2.1847
https://doi.org/10.18502/ken.v3i2.1847